Tg Therapeutics reported $242.22M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 19322M 802M
Ardelyx ARDX:US $ 114.11M 0.12M
Arrowhead Research ARWR:US $ 432.39M 14.76M
Bayer BAYN:GR 39.55B 1.3B
Biogen BIIB:US $ 9740.9M 1825M
Corcept Therapeutics CORT:US $ 419.04M 30.82M
Curis CRIS:US $ 113.4M 12.74M
Dynavax Technologies DVAX:US $ 955.4M 14.89M
Gilead Sciences GILD:US $ 13705M 1076M
Infinity Pharmaceuticals INFI:US $ 59.61M 10.49M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Novartis NOVN:VX 38.14B 906M
Novavax NVAX:US $ 2136M 211.4M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Puma Biotechnology PBYI:US $ 114.28M 3.29M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Spectrum Pharmaceuticals SPPI:US $ 73.58M 19.6M
Verastem VSTM:US $ 97.88M 15.56M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M
Ziopharm Oncology ZIOP:US $ 61.36M 8.41M